blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0574487

EP0574487 - USE OF 5-FLUORO-2'-DEOXY-3'-THIACYTIDINE FOR THE TREATMENT OF HEPATITIS B [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.04.2003
Database last updated on 02.11.2024
Most recent event   Tooltip25.04.2003No opposition filed within time limitpublished on 11.06.2003  [2003/24]
Applicant(s)For all designated states
Emory University
1380 South Oxford Road, N.E.
Atlanta, GA 30322 / US
[N/P]
Former [2001/02]For all designated states
EMORY UNIVERSITY
1380 South Oxford Road, N.E.
Atlanta, GA 30322 / US
Former [1997/42]For all designated states
THE WELLCOME FOUNDATION LIMITED
Glaxo Wellcome House, Berkeley Avenue
Greenford, Middlesex UB6 0NN / GB
Former [1993/51]For all designated states
THE WELLCOME FOUNDATION LIMITED
Unicorn House 160 Euston Road
London NW1 2BP / GB
Inventor(s)01 / LIOTTA, Dennis C.
793 Post Road Way
Stone Mountain, GA 30088 / US
02 / SCHINAZI, Raymond F.
1524 Regency Walk Drive
Decatur, GA 30033 / US
03 / CHOI, Woo-Baeg
4451 Rebel Valley View
Atlanta, GA 30339 / US
[2000/26]
Former [2000/20]01 / LIOTTA, Dennis C.
793 Post Road Way
Stone Mountain, GA 30088 / US
02 / * * *
Former [1993/51]01 / PAINTER, George, Robert, III
108 Pitch Pine Lane
Chapel Hill, NC 27514 / US
02 / FURMAN, Phillip, Allen
901 Bluestone Road
Durham, NC 27713 / US
Representative(s)Hallybone, Huw George, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [1999/40]Hallybone, Huw George, et al
CARPMAELS AND RANSFORD 43 Bloomsbury Square
London WC1A 2RA / GB
Former [1997/42]Garrett, Michael, et al
Glaxo Wellcome plc, Glaxo Wellcome House, Berkeley Avenue
Greenford, Middlesex UB6 0NN / GB
Former [1993/51]Garrett, Michael
The Wellcome Foundation Limited Group Patents and Agreements Langley Court
Beckenham Kent BR3 3BS / GB
Application number, filing date92906520.905.03.1992
[1993/51]
WO1992GB00388
Priority number, dateGB1991000474106.03.1991         Original published format: GB 9104741
GB1991000950502.05.1991         Original published format: GB 9109505
[1993/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9215308
Date:17.09.1992
Language:EN
[1992/24]
Type: A1 Application with search report 
No.:EP0574487
Date:22.12.1993
Language:EN
The application published by WIPO in one of the EPO official languages on 17.09.1992 takes the place of the publication of the European patent application.
[1993/51]
Type: B1 Patent specification 
No.:EP0574487
Date:19.06.2002
Language:EN
[2002/25]
Search report(s)International search report - published on:EP17.09.1992
ClassificationIPC:A61K31/505, C07D411/04
[1993/51]
CPC:
A61K31/70 (EP); A61K31/505 (EP); A61P1/16 (EP);
A61P31/00 (EP); A61P31/12 (EP); A61P31/14 (EP);
A61P31/20 (EP); C07D411/04 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   MC,   NL,   SE [1993/51]
TitleGerman:VERWENDUNG VON 5-FLUORO-2'-DEOXY-3'-THIACYTIDIN ZUR BEHANDLUNG VON HEPATITIS B[1993/51]
English:USE OF 5-FLUORO-2'-DEOXY-3'-THIACYTIDINE FOR THE TREATMENT OF HEPATITIS B[1993/51]
French:UTILISATION DE 5-FLUORO-2'-DESOXY-3'-THIACYTIDINE POUR LE TRAITEMENT DE L'HEPATITE B[1993/51]
Entry into regional phase12.08.1993National basic fee paid 
12.08.1993Designation fee(s) paid 
12.08.1993Examination fee paid 
Examination procedure17.08.1992Request for preliminary examination filed
International Preliminary Examining Authority: DE
12.08.1993Examination requested  [1993/51]
04.09.1998Despatch of a communication from the examining division (Time limit: M08)
11.06.1999Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
19.08.1999Reply to a communication from the examining division
29.08.2000Despatch of a communication from the examining division (Time limit: M04)
04.01.2001Reply to a communication from the examining division
21.03.2001Despatch of communication of intention to grant (Approval: Yes)
03.09.2001Communication of intention to grant the patent
14.09.2001Fee for grant paid
14.09.2001Fee for publishing/printing paid
Divisional application(s)EP01202860.1  / EP1142891
EP07008774.7  / EP1808434
Opposition(s)20.03.2003No opposition filed within time limit [2003/24]
Request for further processing for:19.08.1999Request for further processing filed
19.08.1999Full payment received (date of receipt of payment)
Request granted
06.09.1999Decision despatched
Fees paidRenewal fee
05.01.1994Renewal fee patent year 03
26.01.1995Renewal fee patent year 04
12.01.1996Renewal fee patent year 05
12.03.1997Renewal fee patent year 06
10.03.1998Renewal fee patent year 07
11.03.1999Renewal fee patent year 08
13.03.2000Renewal fee patent year 09
16.03.2001Renewal fee patent year 10
13.03.2002Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]EP0206497  (WELLCOME FOUND [GB]);
 [X]EP0382526  (IAF BIOCHEM INT [CA])
 [XP]  - Proc. Natl. Acad. Sci. USA, vol. 88, no. 19, October 1991, S.-L. DOONG et al.: "Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues", pages 8495-8499, see the whole article
 [Y]  - Gastroenterology, vol. 94, no. 5, part 2, 1988, C. KASSIANIDES et al.: "Effects of 2',3'-dideoxycytidine on duck hepatitis B virus", page A552, see the abstract
ExaminationWO9111186
 WO9214743
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.